Resultados de la búsqueda 81-90 of 17072 for Botox Benefits

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... benefit and resistance to 131I-MIBG and crizotinib. Numeración de páginas Estudios clínicos. AnteriorPágina anterior · Ir a página 3030 · Ir a página 3131 · Ir ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the impact of a recently developed artificial intelligence virtual assistant (AIVA) on plastic surgery patients ...

  4. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn., Jacksonville, Fla. The purpose of this study is to evaluate the probable benefit and safety of the LIPOSORBER® LA-15 System for the treatment ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  7. Bone Marrow Transplant

    Thank you for your interest in becoming a stem cell or bone marrow donor for a loved one in need. If you are a blood relative, please proceed with completing ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation.

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

  10. Metastatic castration-resistant prostate cancer (mCRPC)

    This is called metastatic castration-sensitive prostate cancer (mCSPC). If the cancer spreads and no longer responds to hormone therapy medicines, it's ...